Last updated: February 14, 2024
Sponsor: Nantes University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Macular Edema
Treatment
ACF injection
Clinical Study ID
NCT05996822
AP_JBD_002
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient (Male, Female)°≥ 18 years old
- Having received an AcF injection 1 month after a DXM injection
- For diabetic macular edema or uveitic macular edema
Exclusion
Exclusion Criteria:
- Patient's refusal to allow his or her medical data to be used for research purposes
Study Design
Total Participants: 34
Treatment Group(s): 1
Primary Treatment: ACF injection
Phase:
Study Start date:
January 09, 2024
Estimated Completion Date:
June 30, 2024
Connect with a study center
Jean-Baptiste Ducloyer
Nantes, 44093
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.